These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 23189757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Maintenance of rituximab treatment in a patient with primary Sjögren's syndrome.
    Lehner GF, Brunner-Palka M, Rettenbacher T, Schmidauer R, Herold M.
    Rheumatology (Oxford); 2014 Jul; 53(7):1349-50. PubMed ID: 24446469
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment approaches in primary Sjogren syndrome.
    Vissink A, Kallenberg CG, Bootsma H.
    JAMA; 2010 Nov 10; 304(18):2015-6; author reply 2016. PubMed ID: 21063008
    [No Abstract] [Full Text] [Related]

  • 5. Sustained response to rituximab in a patient with Sjögren´s syndrome and severe refractory polyneuropathy.
    Pertovaara M, Korpela M.
    Clin Exp Rheumatol; 2012 Nov 10; 30(5):808; author reply 809. PubMed ID: 22992382
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rituximab and lupus interstitial lung disease: friend or foe?
    Efthimiou P, Kukar M, Hersh A.
    Int J Rheum Dis; 2011 Feb 10; 14(1):e3-4. PubMed ID: 21303472
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Brief Report: Ultrasonographic Assessment of Salivary Gland Response to Rituximab in Primary Sjögren's Syndrome.
    Jousse-Joulin S, Devauchelle-Pensec V, Cornec D, Marhadour T, Bressollette L, Gestin S, Pers JO, Nowak E, Saraux A.
    Arthritis Rheumatol; 2015 Jun 10; 67(6):1623-8. PubMed ID: 25708147
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry.
    Mekinian A, Ravaud P, Hatron PY, Larroche C, Leone J, Gombert B, Hamidou M, Cantagrel A, Marcelli C, Rist S, Breban M, Launay D, Fain O, Gottenberg JE, Mariette X.
    Ann Rheum Dis; 2012 Jan 10; 71(1):84-7. PubMed ID: 21926185
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry.
    Mekinian A, Ravaud P, Larroche C, Hachulla E, Gombert B, Blanchard-Delaunay C, Cantagrel A, Fain O, Sibilia J, Gottenberg JE, Mariette X, Club Rhumatismes et Inflammation.
    Clin Exp Rheumatol; 2012 Jan 10; 30(2):208-12. PubMed ID: 22341206
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of a patient with primary Sjögren's syndrome with Rituximab.
    Ring T, Kallenbach M, Praetorius J, Nielsen S, Melgaard B.
    Clin Rheumatol; 2006 Nov 10; 25(6):891-4. PubMed ID: 16283417
    [Abstract] [Full Text] [Related]

  • 16. [Sjögren's syndrome: a new approach to treatment].
    Rossier V, Bart PA, Spertini F.
    Rev Med Suisse; 2012 Apr 18; 8(337):843-7. PubMed ID: 22594008
    [Abstract] [Full Text] [Related]

  • 17. Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome.
    Ciccia F, Giardina A, Rizzo A, Guggino G, Cipriani P, Carubbi F, Giacomelli R, Triolo G.
    Ann Rheum Dis; 2013 May 18; 72(5):782-3. PubMed ID: 23264342
    [No Abstract] [Full Text] [Related]

  • 18. Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.
    Ciccia F, Guggino G, Rizzo A, Alessandro R, Carubbi F, Giardina A, Cipriani P, Ferrante A, Cannizzaro A, Giacomelli R, Triolo G.
    Rheumatology (Oxford); 2014 Jul 18; 53(7):1313-20. PubMed ID: 24602921
    [Abstract] [Full Text] [Related]

  • 19. Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome.
    Hershberg U, Meng W, Zhang B, Haff N, St Clair EW, Cohen PL, McNair PD, Li L, Levesque MC, Luning Prak ET.
    Arthritis Res Ther; 2014 Feb 11; 16(1):R51. PubMed ID: 24517398
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.